COH 1.60% $339.06 cochlear limited

Ann: Half Year Report & Accounts , page-7

  1. 4,708 Posts.
    lightbulb Created with Sketch. 197
    the FY 14 results excluding the provision for patent dispute, are in line with the drop in revenue and somewhat the forex movement casper. Sure a profit fall is still a profit fall but it helps to understand the context than just what FY13 vs FY 14 was.

    That said, whether this is a buying opportunity rests on what you forsee happening now: will momentum as the chairman mentioned, pick up going forward as regulatory approvals and new sales come through? If so this will pick back up towards prior year profit levels (maybe not for the full year, given the dismal 1H14, but at least for 2H14).

    I see it going down abit more, and having gotten out post-fall in share price to $58 with the patent dispute, I'm happy to sit tight given the big fall.

    Unsure if $52 now will recover... with a dividend coming up. Might see some more major shareholders bail in next day or two so I might look to get back in on the short term on oversold share price.
 
watchlist Created with Sketch. Add COH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.